Reducing Risk of Dementia Through Deprescribing

Completed · Not applicable

Conditions studied: Dementia, Alzheimer Disease, Late Onset

In brief

A cluster-randomized controlled trial (RCT) called "Reducing Risk of Dementia through Deprescribing" (R2D2) to evaluate the impact of a deprescribing intervention on important cognitive and safety outcomes.

Key facts

Study ID

NCT04270474

Run by

Indiana University

People needed

344

Starts

2020-07-20

Expected to finish

2026-07-29

Last updated by the study team

2026-08-03

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Indiana University Health — Indianapolis, Indiana, United States
• Community Health Network Foundation, Inc. — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.